DCM
RVMD icon

Davis Capital Management’s Revolution Medicines RVMD Stock Holding History

Davis Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749 Buy
+4
New +$584 ﹤0.01% 539

Other funds holding RVMD

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
APM
a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Davis Capital Management's RVMD Position: Q2 2026 in Review

Davis Capital Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 4 shares worth $749. The stake represents ﹤0.01% of the portfolio and ranks #539 among its holdings.

123 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Davis Capital Management held 4 shares of Revolution Medicines worth $749 as of Q2 2026.
  • Revolution Medicines was a new Davis Capital Management position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #539 holding.
  • 123 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.